Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Evaluation of the Bimodal Benefit in a Large Cohort of Cochlear Implant Subjects Using a Contralateral Hearing Aid

Illg, Angelika*; Bojanowicz, Margarete*; Lesinski-Schiedat, Anke*; Lenarz, Thomas*; Büchner, Andreas*†

doi: 10.1097/MAO.0000000000000529
Cochlear Implants
Buy

Objective To investigate the benefit of contralateral residual hearing in a large group of cochlear implant recipients with different degrees of residual hearing.

Patients One hundred and forty-one adult patients (age in years: mean 58.82, min 16.27, max 88.20) wearing a cochlear implant and a contralateral hearing aid, bimodal.

Intervention Rehabilitative.

Main Outcome Measures All 141 patients underwent speech perception testing in quiet and noise with cochlear implant (CI) alone, and with CI and hearing aid (HA). Additionally, pure-tone air conduction threshold levels were measured in all subjects. The bimodal benefit was analyzed and correlations to the hearing threshold for different audiometric frequencies were calculated.

Results Comparison between the scores for CI alone and CI + HA showed statistically significant advantages (p < 0.0001) in all four tests. The benefit for sentences in noise to each individual patient showed a negative correlation with the hearing threshold level of 125 Hz and 250 Hz, using a linear regression analysis applying the Spearman’s rho correlation coefficient (r = −0.32, −0.232), and a significant difference at p = 0.006, p = 0.007. The correlations involving speech understanding in sentences in noise, and the hearing level of 500 Hz and above, are not significant for the benefit obtained with a contralateral hearing aid.

Conclusion The benefit of combined electric and acoustic hearing in bimodally fitted subjects depends mainly on residual hearing in the low-frequency range below 500 Hz. For bimodal fitting to yield significant benefits, hearing loss in the contralateral ear should not exceed 80 dB HL in the low frequencies.

*Department of Otolaryngology, Hannover Medical School, Hannover, Germany; and †Cluster of Excellence, Hearing4All, Medizinische Hochschule Hannover, Germany

Address correspondence and reprint requests to Dr. Angelika Illg, Ph.D., HNO-Klinik der MHH—Deutsches HörZentrum, Karl-Wiechert-Allee 3, 30625 Hannover, Germany; E-mail: illg@hoerzentrum-hannover.de

The authors disclose no conflicts of interest.

Copyright © 2014 by Otology & Neurotology, Inc. Image copyright © 2010 Wolters Kluwer Health/Anatomical Chart Company